RYNCX | RYVLX | RYNCX / RYVLX | |
Total Expense Ratio | 2.31 | 1.74 | 133% |
Annual Report Gross Expense Ratio | 2.37 | 1.87 | 127% |
Fund Existence | 25 years | 21 years | - |
Gain YTD | 16.376 | 27.304 | 60% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 258M | 1.43B | 18% |
Annual Yield % from dividends | 0.80 | 0.00 | - |
Returns for 1 year | 16.64 | 28.41 | 59% |
Returns for 3 years | 63.67 | 246.77 | 26% |
Returns for 5 years | 53.53 | 126.40 | 42% |
Returns for 10 years | 200.06 | 824.40 | 24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 144.76 | 1.30 | +0.91% |
Franklin Biotechnology Discovery C | |||
PFPFX | 56.05 | 0.37 | +0.66% |
Poplar Forest Partners A | |||
VQNPX | 71.43 | 0.32 | +0.45% |
Vanguard Growth & Income Inv | |||
AIVFX | 20.34 | -0.04 | -0.20% |
American Funds International Vntg F-2 | |||
QISIX | 13.42 | -0.09 | -0.67% |
Pear Tree Polaris Intl Opps Instl |